0001193125-15-111498.txt : 20150330 0001193125-15-111498.hdr.sgml : 20150330 20150330151200 ACCESSION NUMBER: 0001193125-15-111498 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150327 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150330 DATE AS OF CHANGE: 20150330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGEN CORP CENTRAL INDEX KEY: 0000711377 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 382367843 STATE OF INCORPORATION: MI FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-17988 FILM NUMBER: 15734132 BUSINESS ADDRESS: STREET 1: 620 LESHER PLACE CITY: LANSING STATE: MI ZIP: 48912 BUSINESS PHONE: 5173729200 MAIL ADDRESS: STREET 1: 620 LESHER PLACE CITY: LANSING STATE: MI ZIP: 48912 8-K 1 d898697d8k.htm 8-K 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 27, 2015

 

 

NEOGEN CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

MICHIGAN   0-17988   38-2367843
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

620 Lesher Place Lansing, Michigan   48912
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code 517-372-9200

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 8.01 Other Events

On March 27, 2015, Neogen Corporation issued a press release announcing Jerome Properties, LLC, has adopted a prearranged trading plan in accordance with Securities and Exchange Commission rule 10b5-1. James Herbert, Chairman and CEO of Neogen Corporation is a minority owner of this entity that owns shares of Neogen Corporation common stock.

Herbert does not have control of this entity, but felt the disclosure was appropriate. The filing is only for a portion of the shares owned by that entity and is a small portion of total shares of Neogen stock held by Herbert or for his benefit.

Rule 10b5-1 of the Securities Exchange Commission permits officers of public companies to adopt predetermined written plans for trading specified amounts of company stock when they are not in possession of material non-public information in order to gradually diversify their investment portfolio and to minimize the market effect of stock sales by spreading them over an extended period of time.

The 10b5-1 Plan adopted by Jerome Properties LLC involves a market order to sell up to 10,000 shares per month of Neogen Corporation common stock each month for one year. The Plan will take effect on April 1, 2015 and expire on March 31, 2016.

The stock transactions under the Rule 10b5-1 Plan will be disclosed publicly through Form 4 filings with the Securities and Exchange Commission. Neogen undertakes no obligation to report on Form 8-K any Rule 10b5-1 plans that may be adopted by any of its other officers and directors or to report on Form 8-K any modifications or termination of any publicly announced trading plans, except to the extent required by law.

Item 9.01 Financial Statements and Exhibits

 

  (d) Exhibits

 

  99.1 Press Release dated March 27, 2015

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEOGEN CORPORATION
(Registrant)
Date: March 30, 2015 /s/ Steven J. Quinlan
Steven J. Quinlan
Vice President & CFO
 EX-99.1 2 d898697dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Neogen CEO Adopts 10b5-1 Trading Plan

LANSING, Mich., March 27, 2015 — Neogen Corporation (NASDAQ: NEOG) announced today that Jerome Properties, LLC, has adopted a prearranged trading plan in accordance with Securities and Exchange Commission rule 10b5-1. James Herbert, Chairman and CEO of Neogen Corporation is a minority owner of this entity that owns shares of Neogen Corporation common stock.

Herbert does not have control of this entity, but felt the disclosure was appropriate. The filing is only for a portion of the shares owned by that entity and is a small portion of total shares of Neogen stock held by Herbert or for his benefit.

Rule 10b5-1 of the Securities Exchange Commission permits officers of public companies to adopt predetermined written plans for trading specified amounts of company stock when they are not in possession of material non-public information in order to gradually diversify their investment portfolio and to minimize the market effect of stock sales by spreading them over an extended period of time.

The 10b5-1 Plan adopted by Jerome Properties LLC involves a market order to sell up to 10,000 shares per month of Neogen Corporation common stock each month for one year. The Plan will take effect on April 1, 2015 and expire on March 31, 2016.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen’s Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.